Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adipose-derived Regenerative Cells in the Treatment of Patients With Chronic Ischemic Heart Disease Not Amenable to Surgical or Interventional Revascularization.

NCT01556022 is registered in ClinicalTrials.gov with Cytori Therapeutics as lead sponsor.

NCT NCT01556022
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01556022 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adipose-derived Regenerative Cells in the Treatment of Patients With Chronic Ischemic Heart Disease Not Amenable to Surgical or Interventional Revascularization.
Lead sponsor
Cytori Therapeutics
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2012
Completion date
October 31, 2016
Enrollment
28 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

myocardial ischemia